热门资讯> 正文

复星制药以3425万美元的价格出售Nature ' s Sunshine股票

2025-06-26 18:51

Fosun Pharma USA is selling up to 2,854,607 shares of common stock held in Nature’s Sunshine Products (NASDAQ:NATR) at a price of $12.00 per share.
The offering is expected to close on June 27, 2025, subject to customary closing conditions.
As part of the offering, Nature’s Sunshine (NASDAQ:NATR) has agreed with Fosun Pharma that it may purchase up to $15M of the shares of its common stock that are subject to the offering from the underwriters at the public offering price as part of its previously announced share repurchase program.
NATR -2.83% premarket.

More on Nature's Sunshine

Nature's Sunshine Products, Inc. (NATR) Q1 2025 Earnings Call Transcript
Nature's Sunshine Products: Near-Term Weakness But Attractive Entry Point For Long-Term Investors
Nature’s Sunshine Products launches secondary public offering of common stock
Nature’s Sunshine CEO to step down following appointment of successor; reaffirms guidance
Seeking Alpha’s Quant Rating on Nature's Sunshine

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。